previous compound ID: 1634 next compound
InChIKey: ORNBQBCIOKFOEO-QGVNFLHTSA-N
SMILES: CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"SD Macknight" "J Goepp" "DY Thomas" "J Liao" "E Matthes" "D Rotin" "GW Carlile" "R Robert" "JW Hanrahan" "B Kus"

chemical graph of compound 1634





CID is 8955
synonyms found at PubChem are:
pregnenolone, 145-13-1, 3beta-Hydroxypregn-5-en-20-one, Arthenolone, Skinostelon, Enelone, Pregnetan, Pregneton, Pregnolon, Prenolon, Regnosone, Bina-Skin, Natolone, 5-Pregnen-3beta-ol-20-one, delta5-Pregnenolone, 5-Pregnen-3-beta-ol-20-one, 5-Pregnenolone, Pregnenolone [INN:BAN], 3-beta-Hydroxypregn-5-en-20-one, NSC 1616, Pregnenolonum [INN-Latin], Pregnenolona [INN-Spanish], (3BETA)-3-HYDROXYPREGN-5-EN-20-ONE, Prestwick_859, UNII-73R90F7MQ8, 3beta-Hydroxy-5-pregnen-20-one, Pregn-5-en-20-one, 3-hydroxy-, (3beta)-, Prestwick3_000546, EINECS 205-647-4, Pregnenolone (JAN/INN), Pregn-5-ene-3beta-ol-20-one, CHEBI:16581, ORNBQBCIOKFOEO-QGVNFLHTSA-N, Pregn-5-en-20-one, 3-hydroxy-, (3-beta)-, 73R90F7MQ8, Pregn-5-en-20-one, 3beta-hydroxy-, 1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone, Pregn-5-en-20-one, 3-beta-hydroxy-, Pregn-5-en-20-one, 3-hydroxy-, (3b)-, DSSTox_CID_16541, DSSTox_RID_79287, DSSTox_GSID_36541, 5-Pregnen-3beta;-ol-20-one, Pregnenolona, Pregnenolonum, PLO, SMR000112161, .DELTA.5-Pregnenolone, Pregnenolone (3beta-Hydroxypregn-5-en-20-one), SR-05000002128, 5-Pregnen-3.beta.-ol-20-one, delta5-Pregnen-3beta-ol-20-one, Pregnolone, 3.beta.-Hydroxypregn-5-en-20-one, NCGC00163125-02, Pregn-5-en-20-one, 3.beta.-hydroxy-, CAS-145-13-1, Prestwick0_000546, Prestwick1_000546, Prestwick2_000546, Spectrum5_002057, bmse000476, D0B4RU, AC1L1S0M, Pregnenolone (schizophrenia), BIDD:PXR0019, BSPBio_000591, MLS002153868, MLS002207138, SCHEMBL129572, SPBio_002512, 3b-Hydroxy-5-pregnen-20-one, BPBio1_000651, CHEMBL253363, GTPL2376, Pregn-5-en-3beta-ol-20-one, DTXSID1036541, MolPort-002-506-906, 3beta-Hydroxy-5-pregnene-20-one, 3beta-hydroxypregn-5-ene-20-one, HMS1569N13, HMS2090J15, HMS2096N13, HMS2268A04, HMS3713N13, Delta5-Pregnene-3beta-ol-20-one, 1-((3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)ethanone, BCP23361, HY-B0151, ZINC3861150, Tox21_112011, Tox21_302141, BDBM50375319, CMC_13393, LMST02030088, MFCD00003628, Pregnenolone (progesterone precursor), s1914, 3beta-Hydroxy-delta5-pregnen-20-one, AKOS015841076, AKOS015895418, Tox21_112011_1, CCG-220546, CS-1970, DB02789, DS-7794, MCULE-4269813571, RL01819, Pregnenolone 0.1 mg/ml in Acetonitrile, .DELTA.5-Pregnen-3.beta.-ol-20-one, 5-Pregnen-3beta-ol-20-one, >=98%, NCGC00163125-03, NCGC00163125-04, NCGC00163125-06, NCGC00255436-01, AC-12806, AN-43964, BC205219, BCP0726000217, Neurosteroid (schizophrenia), Neuroscience, Pregn-5-n-20-ne, 3-ydroxy-, (3)-, Pregnenolone (schizophrenia), Neuroscience, LS-118759, 3-Hydroxypregn-5-en-20-one, (3.beta.)-, 3.beta.-Hydroxy-.DELTA.5-pregnen-20-one, P0786, ST24049035, 3BETA-3-HYDROXY-PREGN-5-EN-20-ONE, Pregn-5-en-20-one, 3beta-hydroxy- (8CI), C01953, D00143, 17beta-[1-Ketoethyl]-Delta5-androsten-3beta-ol, Pregn-5-en-20-one, 3-hydroxy-, (3.beta.)-, 145P131, J-008059, SR-05000002128-4, SR-05000002128-5, BRD-K43880410-001-14-4, 0F6367C4-E1FA-4AEC-9846-7BCC5ADA3417, 1-((3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)ethan-1-one, 1-[(3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16, 17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)]ethanone, 1-[(3S,8S,9S,10R,13S,14S,17S)-10,13-Dimethyl-3-hydroxy-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone, 116907-59-6